StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

ANGOBullishEarningsnews
High materiality8/10

Medical Device Maker AngioDynamics Stock Jumps On Better Than Expected Q3 Earnings, Upbeat Annual Guidance

Apr 2, 2025, 11:01 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The positive earnings and sales growth beat analyst expectations, reflecting improved market conditions. Historically, similar positive reports often lead to significant stock price increases.

AI summary

What happened, with direct paths to the underlying reporting

ANGO's Q3 2025 adjusted EPS was 3 cents, surpassing a 13-cent loss estimate. Sales reached $72 million, beating expectations and up 9.2% year-over-year. Gross margin rose to 54%, a 290 basis point improvement from last year. Fiscal 2025 sales forecast is $285-$288 million, ahead of prior estimates. Stock surged 10.09% to $10.63 following the earnings report.

  • ANGO's Q3 2025 adjusted EPS was 3 cents, surpassing a 13-cent loss estimate.
  • Sales reached $72 million, beating expectations and up 9.2% year-over-year.
  • Gross margin rose to 54%, a 290 basis point improvement from last year.
  • Fiscal 2025 sales forecast is $285-$288 million, ahead of prior estimates.
  • Stock surged 10.09% to $10.63 following the earnings report.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.